TLOG (TetraLogic Pharmaceuticals) EBITDA Margin %: 0.00% (As of Sep. 2016)


What is TetraLogic Pharmaceuticals EBITDA Margin %?

TetraLogic Pharmaceuticals TLOG EBITDA Margin % is 0.00% as of Sep. 2016.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. TetraLogic Pharmaceuticals's EBITDA for the three months ended in Sep. 2016 was $-9.18 Mil. TetraLogic Pharmaceuticals's Revenue for the three months ended in Sep. 2016 was $0.00 Mil. Therefore, TetraLogic Pharmaceuticals's EBITDA margin for the quarter that ended in Sep. 2016 was 0.00%.

TetraLogic Pharmaceuticals  (OTCPK:TLOG) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

TetraLogic Pharmaceuticals EBITDA Margin % Related Terms

TetraLogic Pharmaceuticals EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for TetraLogic Pharmaceuticals's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TetraLogic Pharmaceuticals EBITDA Margin % Chart

TetraLogic Pharmaceuticals Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15
EBITDA Margin %
0.00 0.00 0.00 0.00 0.00

TetraLogic Pharmaceuticals Quarterly Data
Dec11 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

TLOG vs ARGSQ, GTHR, SOAN: EBITDA Margin % Comparison

For the Biotechnology subindustry, TetraLogic Pharmaceuticals's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TetraLogic Pharmaceuticals EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TetraLogic Pharmaceuticals's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where TetraLogic Pharmaceuticals's EBITDA Margin % falls into.


TetraLogic Pharmaceuticals EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

TetraLogic Pharmaceuticals's EBITDA Margin % for the fiscal year that ended in Dec. 2015 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2015 )/Revenue (A: Dec. 2015 )
=-43.152/0
= %

TetraLogic Pharmaceuticals's EBITDA Margin % for the quarter that ended in Sep. 2016 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2016 )/Revenue (Q: Sep. 2016 )
=-9.183/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
TetraLogic Pharmaceuticals (TLOG) has a EBITDA Margin % of 0.00% as of Sep. 2016. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on TetraLogic Pharmaceuticals and its competitors.
Is TetraLogic Pharmaceuticals' EBITDA Margin % too high?
TetraLogic Pharmaceuticals' current EBITDA Margin % is 0.00%.
How does TetraLogic Pharmaceuticals' EBITDA Margin % compare to ARGSQ and GTHR?
TetraLogic Pharmaceuticals' EBITDA Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on TetraLogic Pharmaceuticals and its competitors. TetraLogic Pharmaceuticals's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TetraLogic Pharmaceuticals stock overvalued right now?
TetraLogic Pharmaceuticals (TLOG) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For TetraLogic Pharmaceuticals (TLOG), the current EBITDA Margin % is 0.00% as of Sep. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TetraLogic Pharmaceuticals Business Description

Address 343 Phoenixville Pike, Malvern, PA, USA, 19355
TetraLogic Pharmaceuticals Corp is a biopharmaceutical company. The company is engaged in developing novel small molecule therapeutics in oncology.